Monday Wall Street Ratings Roundup: NVIDIA, Apple, Micron and More Get Bullish Calls from Multiple Firms
0xBroomberg
Wall Street issued a wave of ratings on Monday — Wells Fargo more than doubled its Micron price target from $550 to $1,220, while Nvidia and Apple both had bullish calls reaffirmed. The cluster signals deepening institutional conviction in the AI infrastructure and memory-shortage cycle, with Micron's June 24 earnings as the first proof point.
Why did Micron's price target more than double?
Wells Fargo reaffirmed its overweight rating on Micron (MU) and raised its target from $550 to $1,220 — more than a 2x jump.
The core thesis: the memory supply squeeze will last longer than previously expected, and Micron is executing well on SCA (storage-class acceleration — an architecture that brings memory closer to compute) customer expansion.
This means → Wells Fargo believes this memory up-cycle is far from over. The $1,220 target implies roughly 9x fiscal-2028 EPS — a bet on earnings power two years out.
Micron's June 24 earnings report is the first major test of this thesis.
Nvidia and Cerebras — who is favored in the AI chip race?
RBC Capital Markets reaffirmed its outperform rating on Nvidia (NVDA), arguing Nvidia is best positioned for H2 2026 through 2027 peer competition, with valuations currently attractive.
Morgan Stanley initiated coverage on Cerebras Systems with an overweight rating. Cerebras builds wafer-scale chips — an entire silicon wafer used as one processor, uncut — giving it a unique edge in low-latency inference.
In plain terms = Nvidia is the default pick for AI training; Cerebras targets raw speed on the inference side. That institutions are bullish on both signals the AI chip market is large enough for parallel bets, not a zero-sum game.
What earned Apple a reaffirmed buy?
Bank of America reaffirmed its buy rating on Apple (AAPL), citing this week's WWDC (Worldwide Developers Conference) as an immediate catalyst.
The deeper thesis rests on Apple's long-term edge in AI edge computing — running AI models directly on devices rather than relying entirely on the cloud — and the durability of its capital returns.
This means → BofA is not just betting on a keynote. The real question is whether Apple can embed AI capability at the device level — that determines whether Apple is a participant or a bystander in the AI era.
What shifted in consumer and insurance ratings?
Baird upgraded Crocs (CROX) from neutral to outperform, citing healthier North American recovery signals. Both the Crocs brand and HEYDUDE are reaching a positive inflection, with total revenue expected to return to growth in H2 2026.
Goldman Sachs upgraded W.R. Berkley (WRB) from neutral to buy, arguing the commercial insurer's underwriting margins and return on equity are more sustainable than the market expects.
Bank of America upgraded Brown-Forman (BF.B) from underperform to neutral, after Q4 and fiscal-2026 results came in above expectations.
Which new names got initiated — and what stands out?
JPMorgan initiated Kontoor Brands (KTB) at overweight with a $90 target (December 2027), seeing the company at an earnings inflection point.
JPMorgan also initiated EagleRock Land (EROK) at overweight with a $25 target, bullish on its capital-light land management platform in the Permian Basin.
Goldman Sachs initiated BrightSpring Health Services (BTSG) at buy with a $71 target, calling out industry-leading growth potential in home healthcare.
Piper Sandler initiated Fervo Energy (FRVO) at overweight with a $51 target — even though the geothermal company has rallied nearly 50% since its IPO, Piper sees roughly 35% further upside based on project-level net present value.
Where is the lone downgrade?
Barclays downgraded Avis Budget (CAR) to underweight, while raising its target from $95 to $150.
In plain terms = Barclays is not denying that Avis's fundamentals are improving — it simply believes the stock has outrun the improvement. The current price exceeds what the recovery can reasonably support.
This reflects a deliberate contrarian call in an otherwise bullish ratings cycle: not everything that has risen can keep rising.
Content is for reference only, not financial advice.